Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	99332
Country	China

Received	2024-07-19 17:55
Peer-Review Started	2024-07-19 17:55
To Make the First Decision
Return for Revision	2024-10-23 01:23
Revised	2024-10-23 17:57
Second Decision	2024-11-27 02:32
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-11-27 07:12
Articles in Press	2024-11-27 07:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-11-29 13:54
Publish the Manuscript Online	2025-01-18 08:12

ISSN	1948-5204 (online)
Open Access	Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Editorial
Article Title	Innovative applications and research progress of hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Ting-Fang Yang and Mo-Wei Kong
ORCID	Author(s) ORCID Number Ting-Fang Yang http://orcid.org/0000-0001-5855-6747 Mo-Wei Kong http://orcid.org/0000-0002-1214-164X
Funding Agency and Grant Number
Corresponding Author	Mo-Wei Kong, Department of Cardiology, The Affiliated Hospital of Southwest Medical University, No. 1 Section 1, Xiang Lin Road, Longmatan District, Luzhou 646000, Sichuan Province, China. 1600181272@qq.com
Key Words	Hepatocellular carcinoma; Portal vein tumor thrombus; Hepatic arterial infusion chemotherapy; Comprehensive treatment strategies; Oncology
Core Tip	Hepatic arterial infusion chemotherapy (HAIC) is an innovative regional chemotherapy technique for treating advanced hepatocellular carcinoma. It leverages the differential blood supply between liver tumors and normal liver tissue to deliver high concentrations of chemotherapy drugs directly to tumor tissues, enhancing efficacy while minimizing systemic side effects. Recent advancements in interventional radiology have made precise drug delivery possible, improving the safety and operability of HAIC. The combination of HAIC with targeted therapy and immunotherapy offers a more comprehensive and personalized treatment approach for hepatocellular carcinoma patients.
Publish Date	2025-01-18 08:12
Citation	<p>Yang TF, Kong MW. Innovative applications and research progress of hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma. <i>World J Gastrointest Oncol</i> 2025; 17(2): 99332</p>
URL	https://www.wjgnet.com/1948-5204/full/v17/i2/99332.htm
DOI	https://dx.doi.org/10.4251/wjgo.v17.i2.99332

Full Article (PDF)	WJGO-17-99332-with-cover.pdf
Manuscript File	99332_Auto_Edited_014730.docx
Answering Reviewers	99332-answering-reviewers.pdf
Audio Core Tip	99332-audio.wav
Conflict-of-Interest Disclosure Form	99332-conflict-of-interest-statement.pdf
Copyright License Agreement	99332-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	99332-non-native-speakers.pdf
Peer-review Report	99332-peer-reviews.pdf
Scientific Misconduct Check	99332-scientific-misconduct-check.png
Scientific Editor Work List	99332-scientific-editor-work-list.pdf
CrossCheck Report	99332-crosscheck-report.pdf